β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation

被引:49
作者
Cai, Yan [2 ,3 ]
Xiong, Kun [2 ]
Zhang, Xue-Mei [1 ,4 ]
Cai, Huaibin [5 ]
Luo, Xue-Gang [2 ]
Feng, Jia-Chun [4 ]
Clough, Richard W. [1 ]
Struble, Robert G. [6 ]
Patrylo, Peter R. [1 ,3 ]
Chu, Yaping [7 ]
Kordower, Jeffrey H. [7 ]
Yan, Xiao-Xin [1 ]
机构
[1] So Illinois Univ, Sch Med Carbondale, Dept Anat, Carbondale, IL 62901 USA
[2] Cent S Univ, Xiangya Med Sch, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China
[3] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA
[4] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Jilin, Peoples R China
[5] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[6] So Illinois Univ, Sch Med, Ctr Alzheimers Dis, Carbondale, IL 62901 USA
[7] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
关键词
aging; dementia; hypometabolism; neuritic plaque; neuroplasticity; non-human primate; MILD COGNITIVE IMPAIRMENT; A-BETA; CEREBROSPINAL-FLUID; DYSTROPHIC NEURITES; SECRETASE BACE1; RHESUS-MONKEYS; PLAQUES; PROTEIN; PATHOLOGY; ENZYME;
D O I
10.1111/j.1460-9568.2010.07376.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is the most common dementia-causing disorder in the elderly; it may be related to multiple risk factors, and is characterized pathologically by cerebral hypometabolism, paravascular beta-amyloid peptide (A beta) plaques, neuritic dystrophy, and intra-neuronal aggregation of phosphorylated tau. To explore potential pathogenic links among some of these lesions, we examined beta-secretase-1 (BACE1) alterations relative to A beta deposition, neuritic pathology and vascular organization in aged monkey and AD human cerebral cortex. Western blot analyses detected increased levels of BACE1 protein and beta-site-cleavage amyloid precursor protein C-terminal fragments in plaque-bearing human and monkey cortex relative to controls. In immunohistochemistry, locally elevated BACE1 immunoreactivity (IR) occurred in AD but not in control human cortex, with a trend for increased overall density among cases with greater plaque pathology. In double-labeling preparations, BACE1 IR colocalized with immunolabeling for A beta but not for phosphorylated tau. In perfusion-fixed monkey cortex, locally increased BACE1 IR co-existed with intra-axonal and extracellular A beta IR among virtually all neuritic plaques, ranging from primitive to typical cored forms. This BACE1 labeling localized to swollen/sprouting axon terminals that might co-express one or another neuronal phenotype markers (GABAergic, glutamatergic, cholinergic, or catecholaminergic). Importantly, these BACE1-labeled dystrophic axons resided near to or in direct contact with blood vessels. These findings suggest that plaque formation in AD or normal aged primates relates to a multisystem axonal pathogenesis that occurs in partnership with a potential vascular or metabolic deficit. The data provide a mechanistic explanation for why senile plaques are present preferentially near the cerebral vasculature.
引用
收藏
页码:1223 / 1238
页数:16
相关论文
共 58 条
  • [1] An energy budget for signaling in the grey matter of the brain
    Attwell, D
    Laughlin, SB
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (10) : 1133 - 1145
  • [2] Consequence of A immunization on the vasculature of human Alzheimers disease brain
    Boche, D.
    Zotova, E.
    Weller, R. O.
    Love, S.
    Neal, J. W.
    Pickering, R. M.
    Wilkinson, D.
    Holmes, C.
    Nicoll, J. A. R.
    [J]. BRAIN, 2008, 131 : 3299 - 3310
  • [3] Modeling an Anti-Amyloid Combination Therapy for Alzheimer's Disease
    Chow, Vivian W.
    Savonenko, Alena V.
    Melnikova, Tatiana
    Kim, Hyunsu
    Price, Donald L.
    Li, Tong
    Wong, Philip C.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (13) : 13ra1
  • [4] Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion:: Is this the target for Parkinson's disease?
    Chu, Yaping
    Kordower, Jeffrey H.
    [J]. NEUROBIOLOGY OF DISEASE, 2007, 25 (01) : 134 - 149
  • [5] Basal Cerebral Metabolism May Modulate the Cognitive Effects of Aβ in Mild Cognitive Impairment: An Example of Brain Reserve
    Cohen, Ann D.
    Price, Julie C.
    Weissfeld, Lisa A.
    James, Jeffrey
    Rosario, Bedda L.
    Bi, Wenzhu
    Nebes, Robert D.
    Saxton, Judith A.
    Snitz, Beth E.
    Aizenstein, Howard A.
    Wolk, David A.
    DeKosky, Steven T.
    Mathis, Chester A.
    Klunk, William E.
    [J]. JOURNAL OF NEUROSCIENCE, 2009, 29 (47) : 14770 - 14778
  • [6] Linking vascular disorders and Alzheimer's disease: Potential involvement of BACE1
    Cole, Sarah L.
    Vassar, Robert
    [J]. NEUROBIOLOGY OF AGING, 2009, 30 (10) : 1535 - 1544
  • [7] The secretases: enzymes with therapeutic potential in Alzheimer disease
    De Strooper, Bart
    Vassar, Robert
    Golde, Todd
    [J]. NATURE REVIEWS NEUROLOGY, 2010, 6 (02) : 99 - 107
  • [8] The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease
    Dickson, TC
    Vickers, JC
    [J]. NEUROSCIENCE, 2001, 105 (01) : 99 - 107
  • [9] Classification and basic pathology of Alzheimer disease
    Duyckaerts, Charles
    Delatour, Benoit
    Potier, Marie-Claude
    [J]. ACTA NEUROPATHOLOGICA, 2009, 118 (01) : 5 - 36
  • [10] Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease
    Ewers, Michael
    Zhong, Zhenyu
    Buerger, Katharina
    Wallin, Anders
    Blennow, Kaj
    Teipel, Stefan J.
    Shen, Yong
    Hampel, Harald
    [J]. BRAIN, 2008, 131 : 1252 - 1258